|
1
|
Reduction of B cell turnover in chronic lymphocytic leukaemia.
|
Br J Haematol
|
2008
|
1.74
|
|
2
|
Measurement and modeling of human T cell kinetics.
|
Eur J Immunol
|
2003
|
1.61
|
|
3
|
B-cell kinetics in humans: rapid turnover of peripheral blood memory cells.
|
Blood
|
2005
|
1.52
|
|
4
|
In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection.
|
Immunology
|
2007
|
1.35
|
|
5
|
HLA class I binding of HBZ determines outcome in HTLV-1 infection.
|
PLoS Pathog
|
2010
|
1.28
|
|
6
|
Cell dynamics and immune response to BLV infection: a unifying model.
|
Front Biosci
|
2007
|
1.13
|
|
7
|
The role of CTLs in persistent viral infection: cytolytic gene expression in CD8+ lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1.
|
J Immunol
|
2004
|
1.11
|
|
8
|
High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease.
|
J Virol
|
2003
|
1.10
|
|
9
|
Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy.
|
J Infect Dis
|
2004
|
1.04
|
|
10
|
Rapid turnover of T cells in acute infectious mononucleosis.
|
Eur J Immunol
|
2003
|
1.03
|
|
11
|
KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection.
|
PLoS Pathog
|
2011
|
1.02
|
|
12
|
Closing the gap between T-cell life span estimates from stable isotope-labeling studies in mice and humans.
|
Blood
|
2013
|
1.01
|
|
13
|
Increased cell proliferation, but not reduced cell death, induces lymphocytosis in bovine leukemia virus-infected sheep.
|
Proc Natl Acad Sci U S A
|
2002
|
1.01
|
|
14
|
The immune control of HTLV-1 infection: selection forces and dynamics.
|
Front Biosci (Landmark Ed)
|
2009
|
1.00
|
|
15
|
In vivo expression of human T-lymphotropic virus type 1 basic leucine-zipper protein generates specific CD8+ and CD4+ T-lymphocyte responses that correlate with clinical outcome.
|
J Infect Dis
|
2011
|
1.00
|
|
16
|
Peripheral blood B-cell death compensates for excessive proliferation in lymphoid tissues and maintains homeostasis in bovine leukemia virus-infected sheep.
|
J Virol
|
2006
|
0.99
|
|
17
|
T-cell epitope prediction: rescaling can mask biological variation between MHC molecules.
|
PLoS Comput Biol
|
2009
|
0.99
|
|
18
|
The avidity and lytic efficiency of the CTL response to HTLV-1.
|
J Immunol
|
2009
|
0.99
|
|
19
|
Histone deacetylase mediated transcriptional activation reduces proviral loads in HTLV-1 associated myelopathy/tropical spastic paraparesis patients.
|
Blood
|
2007
|
0.98
|
|
20
|
HTLV-1: persistence and pathogenesis.
|
Virology
|
2013
|
0.97
|
|
21
|
Safety of long-term treatment of HAM/TSP patients with valproic acid.
|
Blood
|
2011
|
0.97
|
|
22
|
Measurement of proliferation and disappearance of rapid turnover cell populations in human studies using deuterium-labeled glucose.
|
Nat Protoc
|
2009
|
0.95
|
|
23
|
Why don't CD8+ T cells reduce the lifespan of SIV-infected cells in vivo?
|
PLoS Comput Biol
|
2011
|
0.95
|
|
24
|
Quantification of the relative importance of CTL, B cell, NK cell, and target cell limitation in the control of primary SIV-infection.
|
PLoS Comput Biol
|
2011
|
0.92
|
|
25
|
Quantifying the impact of human immunodeficiency virus-1 escape from cytotoxic T-lymphocytes.
|
PLoS Comput Biol
|
2010
|
0.88
|
|
26
|
Can non-lytic CD8+ T cells drive HIV-1 escape?
|
PLoS Pathog
|
2013
|
0.87
|
|
27
|
Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo.
|
PLoS Pathog
|
2013
|
0.86
|
|
28
|
Cell-mediated immune response to human T-lymphotropic virus type I.
|
Viral Immunol
|
2005
|
0.86
|
|
29
|
Reduced cell turnover in bovine leukemia virus-infected, persistently lymphocytotic cattle.
|
J Virol
|
2003
|
0.85
|
|
30
|
Spleen-dependent turnover of CD11b peripheral blood B lymphocytes in bovine leukemia virus-infected sheep.
|
J Virol
|
2006
|
0.83
|
|
31
|
Reduced cell turnover in lymphocytic monkeys infected by human T-lymphotropic virus type 1.
|
Oncogene
|
2005
|
0.82
|
|
32
|
Viral expression directs the fate of B cells in bovine leukemia virus-infected sheep.
|
J Virol
|
2011
|
0.81
|
|
33
|
Earlier onset of delta-retrovirus-induced leukemia after splenectomy.
|
PLoS One
|
2009
|
0.81
|
|
34
|
Gene activation therapy: from the BLV model to HAM/TSP patients.
|
Front Biosci (Schol Ed)
|
2009
|
0.79
|
|
35
|
The efficiency of the human CD8+ T cell response: how should we quantify it, what determines it, and does it matter?
|
PLoS Comput Biol
|
2012
|
0.79
|
|
36
|
HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP.
|
Virol J
|
2014
|
0.77
|
|
37
|
In contrast to HIV, KIR3DS1 does not influence outcome in HTLV-1 retroviral infection.
|
Hum Immunol
|
2012
|
0.76
|
|
38
|
Short communication an interferon-γ ELISPOT assay with two cytotoxic T cell epitopes derived from HTLV-1 tax region 161-233 discriminates HTLV-1-associated myelopathy/tropical spastic paraparesis patients from asymptomatic HTLV-1 carriers in a Peruvian population.
|
AIDS Res Hum Retroviruses
|
2011
|
0.75
|